T. Murakami et al., Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus, AM J CARD, 84(1), 1999, pp. 92
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
This study investigates the effects of troglitazone, an insulin sensitizer,
on the clinical manifestation of coronary vasospastic angina pectoris in p
atients with diabetes mellitus. Troglitazone reduces frequency of angina pe
ctoris and improves endothelial function.